Last reviewed · How we verify
ARMLUPEG (PEGFILGRASTIM-UNNE)
ARMLUPEG (generic name: PEGFILGRASTIM-UNNE) is a Leukocyte Growth Factor [EPC] drug developed by LUPIN LTD. It is currently FDA-approved.
At a glance
| Generic name | PEGFILGRASTIM-UNNE |
|---|---|
| Sponsor | LUPIN LTD |
| Drug class | Leukocyte Growth Factor [EPC] |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
- Bone pain
- Pain in extremity
Serious adverse events
- Splenic rupture
- Acute respiratory distress syndrome
- Serious hypersensitivity reactions
- Glomerulonephritis
- Leukocytosis
- Thrombocytopenia
- Capillary leak syndrome
- Myelodysplastic syndrome
- Acute myeloid leukemia
- Aortitis
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ARMLUPEG CI brief — competitive landscape report
- ARMLUPEG updates RSS · CI watch RSS
- LUPIN LTD portfolio CI
Frequently asked questions about ARMLUPEG
What is ARMLUPEG?
ARMLUPEG (PEGFILGRASTIM-UNNE) is a Leukocyte Growth Factor [EPC] drug developed by LUPIN LTD.
Who makes ARMLUPEG?
ARMLUPEG is developed and marketed by LUPIN LTD (see full LUPIN LTD pipeline at /company/lupin-ltd).
What is the generic name of ARMLUPEG?
PEGFILGRASTIM-UNNE is the generic (nonproprietary) name of ARMLUPEG.
What drug class is ARMLUPEG in?
ARMLUPEG belongs to the Leukocyte Growth Factor [EPC] class. See all Leukocyte Growth Factor [EPC] drugs at /class/leukocyte-growth-factor-epc.
What development phase is ARMLUPEG in?
ARMLUPEG is FDA-approved (marketed).
What are the side effects of ARMLUPEG?
Common side effects of ARMLUPEG include Bone pain, Pain in extremity. Serious adverse events: Splenic rupture, Acute respiratory distress syndrome, Serious hypersensitivity reactions, Glomerulonephritis.
Related
- Drug class: All Leukocyte Growth Factor [EPC] drugs
- Manufacturer: LUPIN LTD — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing